SI-BONE, Inc. (SIBN)

Market Cap	762.23M
Revenue (ttm)	131.98M
Net Income (ttm)	-43.53M
Shares Out	40.50M
EPS (ttm)	-1.19
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	395,325
Open	18.94
Previous Close	18.96
Day's Range	18.32 - 19.08
52-Week Range	11.23 - 29.51
Beta	0.99
Analysts	Strong Buy
Price Target	26.57 (+41.18%)
Earnings Date	Nov 6, 2023

About SIBN

SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers proprietary minimally invasive surgical implant system to address sacroiliac joint dysfunction and fusion, adult deformity and degeneration, and pelvic trauma. The company also provides iFuse-3D, a titanium implant that combines the triangular cross-section of the iFuse implant with the proprietary 3D-printed porous surface and fenestrated design; iFuse-TORQ,...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 17, 2018
• Employees: 357
• Stock Exchange: NASDAQ
• Ticker Symbol: SIBN

Financial Performance

In 2022, SI-BONE's revenue was $106.41 million, an increase of 18.03% compared to the previous year's $90.15 million. Losses were -$61.26 million, 8.28% more than in 2021.

Analyst Forecast

According to 7 analysts, the average rating for SIBN stock is "Strong Buy." The 12-month stock price forecast is $26.57, which is an increase of 41.18% from the latest price.

Price Target

$26.57

(41.18% upside)

Analyst Consensus: Strong Buy